ORINOVA is developing a breakthrough innovation in oncology with a patented nanomedicine incorporating a unique dual therapy: a chemotherapy molecule combined with gold nanoparticles. This combination amplifies the effect of radiotherapy, optimizes the efficacy of chemotherapy and enables tumors to be targeted via intra-tumoral administration, thus limiting side effects for patients. This intelligent nano-object could revolutionize the treatment of particularly resistant solid tumors as GBM.